Studies on efficacy of treatment with sulfamethoxazole + trimethoprim and sulfalene + pyrimethamine combinations in Plasmodium falciparum malaria of known and unknown resistant status.
Barkakaty
B N
BN
Sharma
G K
GK
Chakravorty
N K
NK
D000818:Animals; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006801:Humans; D007194:India; D008288:Malaria / Q000188:drug therapy*; D010963:Plasmodium falciparum / Q000187:drug effects*; D011739:Pyrimethamine / Q000008:administration & dosage*; D013415:Sulfalene / Q000008:administration & dosage*; D013420:Sulfamethoxazole / Q000008:administration & dosage*; D013424:Sulfanilamides / Q000008:administration & dosage*; D014295:Trimethoprim / Q000008:administration & dosage*
D013424:Sulfanilamides; D014295:Trimethoprim; D013420:Sulfamethoxazole; D013415:Sulfalene; D011739:Pyrimethamine